Correction to: Cardiac and kidney benefits of empagliflozin in heart failure across the spectrum of kidney function: Insights from EMPEROR-reduced
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
26 January 2021
|
| In: |
Circulation
Year: 2021, Jahrgang: 143, Heft: 4, Pages: E29-E29 |
| ISSN: | 1524-4539 |
| DOI: | 10.1161/CIR.0000000000000953 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1161/CIR.0000000000000953 Verlag, lizenzpflichtig, Volltext: https://www.ahajournals.org/doi/10.1161/CIR.0000000000000953 |
| Verfasserangaben: | Faiez Zannad, João Pedro Ferreira, Stuart J. Pocock, Cordula Zeller, Stefan D. Anker, Javed Butler, Gerasimos Filippatos, Sibylle Jenny Hauske, Martina Brueckmann, Egon Pfarr, Janet Schnee, Christoph Wanner and Milton Packer |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1762486628 | ||
| 003 | DE-627 | ||
| 005 | 20220820013050.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210708s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1161/CIR.0000000000000953 |2 doi | |
| 035 | |a (DE-627)1762486628 | ||
| 035 | |a (DE-599)KXP1762486628 | ||
| 035 | |a (OCoLC)1341418252 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Zannad, Faiez |d 1951- |e VerfasserIn |0 (DE-588)141665009 |0 (DE-627)704036290 |0 (DE-576)182926400 |4 aut | |
| 245 | 1 | 0 | |a Correction to: Cardiac and kidney benefits of empagliflozin in heart failure across the spectrum of kidney function |b Insights from EMPEROR-reduced |c Faiez Zannad, João Pedro Ferreira, Stuart J. Pocock, Cordula Zeller, Stefan D. Anker, Javed Butler, Gerasimos Filippatos, Sibylle Jenny Hauske, Martina Brueckmann, Egon Pfarr, Janet Schnee, Christoph Wanner and Milton Packer |
| 264 | 1 | |c 26 January 2021 | |
| 300 | |a 1 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 08.07.2021 | ||
| 700 | 1 | |a Ferreira, João Pedro |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pocock, Stuart J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Zeller, Cordula |e VerfasserIn |4 aut | |
| 700 | 1 | |a Anker, Stefan D. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Butler, Javed |e VerfasserIn |4 aut | |
| 700 | 1 | |a Filippatos, Gerasimos |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hauske, Sibylle J. |d 1976-2025 |e VerfasserIn |0 (DE-588)137856253 |0 (DE-627)596151527 |0 (DE-576)305349686 |4 aut | |
| 700 | 1 | |a Brückmann, Martina |d 1970- |e VerfasserIn |0 (DE-588)121145069 |0 (DE-627)705257290 |0 (DE-576)292557736 |4 aut | |
| 700 | 1 | |a Pfarr, Egon |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schnee, Janet |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wanner, Christoph |e VerfasserIn |4 aut | |
| 700 | 1 | |a Packer, Milton |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Circulation |d Philadelphia, Pa. : Lippincott, Williams & Wilkins, 1950 |g 143(2021), 4, Seite E29-E29 |h Online-Ressource |w (DE-627)265784670 |w (DE-600)1466401-X |w (DE-576)074891189 |x 1524-4539 |7 nnas |a Correction to: Cardiac and kidney benefits of empagliflozin in heart failure across the spectrum of kidney function Insights from EMPEROR-reduced |
| 773 | 1 | 8 | |g volume:143 |g year:2021 |g number:4 |g pages:E29-E29 |g extent:1 |a Correction to: Cardiac and kidney benefits of empagliflozin in heart failure across the spectrum of kidney function Insights from EMPEROR-reduced |
| 787 | 0 | 8 | |i Errata zu |a Zannad, Faiez, 1951 - |t Cardiac and kidney benefits of empagliflozin in heart failure across the spectrum of kidney function |d 2021 |w (DE-627)1762482657 |
| 856 | 4 | 0 | |u https://doi.org/10.1161/CIR.0000000000000953 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.ahajournals.org/doi/10.1161/CIR.0000000000000953 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220420 | ||
| 993 | |a Article | ||
| 994 | |a 2021 | ||
| 998 | |g 121145069 |a Brückmann, Martina |m 121145069:Brückmann, Martina |d 60000 |e 60000PB121145069 |k 0/60000/ |p 9 | ||
| 998 | |g 137856253 |a Hauske, Sibylle J. |m 137856253:Hauske, Sibylle J. |d 60000 |d 61400 |e 60000PH137856253 |e 61400PH137856253 |k 0/60000/ |k 1/60000/61400/ |p 8 | ||
| 999 | |a KXP-PPN1762486628 |e 4119034364 | ||
| BIB | |a Y | ||
| SER | |a newspaper | ||
| JSO | |a {"id":{"doi":["10.1161/CIR.0000000000000953"],"eki":["1762486628"]},"physDesc":[{"extent":"1 S."}],"note":["Gesehen am 08.07.2021"],"relHost":[{"disp":"Correction to: Cardiac and kidney benefits of empagliflozin in heart failure across the spectrum of kidney function Insights from EMPEROR-reducedCirculation","physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["265784670"],"issn":["1524-4539"],"zdb":["1466401-X"]},"note":["Gesehen am 10.10.2025"],"corporate":[{"role":"isb","display":"American Heart Association"}],"type":{"media":"Online-Ressource","bibl":"newspaper"},"origin":[{"publisherPlace":"Philadelphia, Pa. ; [Erscheinungsort nicht ermittelbar]","dateIssuedKey":"1950","publisher":"Lippincott, Williams & Wilkins ; Ovid","dateIssuedDisp":"1950-"}],"recId":"265784670","title":[{"title":"Circulation","subtitle":"an official journal of the American Heart Association","title_sort":"Circulation"}],"part":{"volume":"143","year":"2021","text":"143(2021), 4, Seite E29-E29","pages":"E29-E29","extent":"1","issue":"4"},"language":["eng"],"pubHistory":["1.1950 -"]}],"recId":"1762486628","origin":[{"dateIssuedDisp":"26 January 2021","dateIssuedKey":"2021"}],"type":{"media":"Online-Ressource","bibl":"article-newspaper"},"person":[{"given":"Faiez","role":"aut","display":"Zannad, Faiez","family":"Zannad"},{"family":"Ferreira","given":"João Pedro","role":"aut","display":"Ferreira, João Pedro"},{"given":"Stuart J.","role":"aut","display":"Pocock, Stuart J.","family":"Pocock"},{"given":"Cordula","role":"aut","display":"Zeller, Cordula","family":"Zeller"},{"family":"Anker","given":"Stefan D.","role":"aut","display":"Anker, Stefan D."},{"family":"Butler","display":"Butler, Javed","given":"Javed","role":"aut"},{"display":"Filippatos, Gerasimos","role":"aut","given":"Gerasimos","family":"Filippatos"},{"family":"Hauske","given":"Sibylle J.","role":"aut","display":"Hauske, Sibylle J."},{"family":"Brückmann","role":"aut","given":"Martina","display":"Brückmann, Martina"},{"family":"Pfarr","role":"aut","given":"Egon","display":"Pfarr, Egon"},{"display":"Schnee, Janet","role":"aut","given":"Janet","family":"Schnee"},{"family":"Wanner","display":"Wanner, Christoph","role":"aut","given":"Christoph"},{"family":"Packer","given":"Milton","role":"aut","display":"Packer, Milton"}],"name":{"displayForm":["Faiez Zannad, João Pedro Ferreira, Stuart J. Pocock, Cordula Zeller, Stefan D. Anker, Javed Butler, Gerasimos Filippatos, Sibylle Jenny Hauske, Martina Brueckmann, Egon Pfarr, Janet Schnee, Christoph Wanner and Milton Packer"]},"title":[{"title":"Correction to: Cardiac and kidney benefits of empagliflozin in heart failure across the spectrum of kidney function","subtitle":"Insights from EMPEROR-reduced","title_sort":"Correction to: Cardiac and kidney benefits of empagliflozin in heart failure across the spectrum of kidney function"}],"language":["eng"]} | ||
| SRT | |a ZANNADFAIECORRECTION2620 | ||